Literature DB >> 16037935

Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging.

Clement T Loy1, Mary G Sweeney, Mary B Davis, Adrian J Wills, Guy V Sawle, Andrew J Lees, Sarah J Tabrizi.   

Abstract

We report on a 50-year-old woman who presented with an 8-year history of involuntary movements, unsteadiness, and cognitive decline. Examination revealed multidomain cognitive deficits, jerky ocular pursuit movements, hypometric saccades, gaze impersistence, dysarthria, upper limb dystonia, and widespread chorea. TATA-binding protein gene test revealed trinucleotide expansion allele sizes of 47 and 39 repeats, confirming the diagnosis of spinocerebellar ataxia type 17 (SCA-17). Magnetic resonance imaging (MRI) showed marked cerebellar atrophy and putaminal rim hyperintensity. This is the first case of SCA-17 reported to show MRI signal change in the basal ganglia, and extends the phenotypic manifestation of SCA-17.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037935     DOI: 10.1002/mds.20529

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Spinocerebellar ataxia type 17 in a patient from an Indian kindred.

Authors:  Dietrich Haubenberger; Daniela Prayer; Peter Bauer; Walter Pirker; Alexander Zimprich; Eduard Auff
Journal:  J Neurol       Date:  2006-09-13       Impact factor: 4.849

2.  Magnetic resonance imaging in spinocerebellar ataxias.

Authors:  Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family.

Authors:  Susanne A Schneider; Kate E Marshall; Jianfeng Xiao; Mark S LeDoux
Journal:  Neurogenetics       Date:  2012-03-25       Impact factor: 2.660

Review 4.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

Review 5.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

6.  Investigating function and connectivity of morphometric findings--exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17).

Authors:  Kathrin Reetz; Imis Dogan; Arndt Rolfs; Ferdinand Binkofski; Jörg B Schulz; Angela R Laird; Peter T Fox; Simon B Eickhoff
Journal:  Neuroimage       Date:  2012-05-30       Impact factor: 6.556

7.  Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17.

Authors:  Kathrin Reetz; Rebekka Lencer; Johannes M Hagenah; Christian Gaser; Vera Tadic; Uwe Walter; Alexander Wolters; Susanne Steinlechner; Christine Zühlke; Katja Brockmann; Christine Klein; Arndt Rolfs; Ferdinand Binkofski
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

Review 8.  Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.

Authors:  Christine Zühlke; Katrin Bürk
Journal:  Cerebellum       Date:  2007-01-19       Impact factor: 3.847

9.  Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).

Authors:  Giovanni Stevanin; Alexis Brice
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 10.  Neuroimaging in dementia.

Authors:  Paolo Vitali; Raffaella Migliaccio; Federica Agosta; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2008-10-08       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.